Healthcare

Global Point-of-care Testing Growth Opportunities Updated Research Available

Molecular POCT Unlocking Growth Potential in the Distributed Diagnostic Data Ecosystem

INDUSTRY
Healthcare

RELEASE DATE
15-Nov-2023
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
K973-01-00-00-00
SKU
HC_2023_319
Yes
SHARE

Global Point-of-care Testing Growth Opportunities
Published on: 15-Nov-2023 | SKU: HC_2023_319

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

This study provides an overview of the global point-of-care testing (POCT) industry, which refers to any routine or specialized lab pathology
testing conducted rapidly, on-site/near the site of the patient, where care or treatment is provided. COVID-19 radicalization is changing the global diagnostics landscape. Consolidation trends, structural shifts in healthcare settings, and the extension of POCT to sexually transmitted infections (STIs), antimicrobial resistance (AMR), routine testing, oncology, and newborn screening are shaping new frontiers. In the future, therapy areas such as oncology, stroke, and dementia will represent the POCT repertoire.

In developed economies, the proliferation of syndromic testing, multiplexing making inroads in immunoassay, evolution in nucleic acid
amplification technology (from PCR to Isothermal Amplification), the use of saliva specimens, and advancements in antimicrobial resistance
testing are increasing the market viability. Furthermore, AI/ML-enabled device software functions incorporating predetermined change control
plans under the diagnostic data program initiative offer accelerated market opportunities in the United States.

In developing economies, multiparametric platforms have emerged to respond to an escalating POC demand in emergency departments and
small-medium labs. In addition, a strong pull toward preventive health is laying the foundation to advance routine testing using emerging blood testing platforms.

A robust multiplex ecosystem tied with the converging potential of diagnostic data creating new revenue streams (e.g., connectivity and digital healthcare technology services) exemplifies the pivot from COVID-19 testing, adapting to changing clinical pathways and greater harmonization
of lab-based and non-lab-based diagnostic data for similar tests to build a more sustainable point-of-care ecosystem.

Author: Amartya Bose

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Point-of-care Testing (POCT) Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Scope of Analysis (continued)

Segmentation—Test Type

Segmentation—Care Continuum

Key Competitors

Growth Metrics

Growth Drivers

Growth Drivers (continued)

Growth Restraints

Growth Restraints (continued)

Forecast Assumptions

Revenue Forecast

Revenue Forecast by Test Type

Revenue Forecast by Region

Revenue Forecast by Care Continuum

Forecast Analysis

Forecast Analysis (continued)

Forecast Analysis (continued)

Forecast Analysis (continued)

Forecast Analysis (continued)

Forecast Analysis (continued)

Pricing Trends and Forecast Analysis

Competitive Environment

POCT Across Different Therapy Areas

Revenue Share

Revenue Share Analysis

Revenue Share Analysis (continued)

Revenue Share Analysis (continued)

Revenue Share Analysis (continued)

Competitor Matrix—Therapy Areas

Competitor Matrix—Technology Mapping

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Revenue Forecast by Immunochemistry POCT

Forecast Analysis

Forecast Analysis (continued)

Forecast Analysis (continued)

Forecast Analysis (continued)

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Revenue Forecast by Molecular POCT Therapy Areas

Forecast Analysis

Forecast Analysis (continued)

Forecast Analysis (continued)

Forecast Analysis (continued)

Growth Opportunity 1: Molecular POCT

Growth Opportunity 1: Molecular POCT (continued)

Growth Opportunity 2: Multiplexing

Growth Opportunity 2: Multiplexing (continued)

Growth Opportunity 3: STI POCT

Growth Opportunity 3: STI POCT (continued)

Growth Opportunity 4: AMR POCT

Growth Opportunity 4: AMR POCT (continued)

Growth Opportunity 5: Routine POCT

Growth Opportunity 5: Routine POCT (continued)

Growth Opportunity 6: Smartphone POCT

Growth Opportunity 6: Smartphone POCT (continued)

Future of POCT in Care Continuum

Your Next Steps

Why Frost, Why Now?

List of Exhibits

Legal Disclaimer

List of Figures
  • POCT Industry: Growth Metrics, Global, 2023
  • POCT Industry: Growth Drivers, Global, 2024–2028
  • POCT Industry: Growth Restraints, Global, 2024–2028
  • POCT Industry: Revenue Forecast, Global, 2023–2028
  • POCT Industry: Revenue Forecast by Test Type, Global, 2023–2028
  • POCT Industry: Revenue Forecast by Region, 2023–2028
  • POCT Industry: Revenue Forecast by Care Continuum, Global, 2023–2028
  • POCT Industry: Revenue Share of Top Participants, Global, 2023
  • POCT Industry: Competitor Matrix for Therapy Area Portfolio Assessment, Global, 2023
  • Immunochemistry POCT: Growth Metrics, Global, 2023
  • Immunochemistry POCT: Revenue Forecast, Global, 2023–2028
  • Immunochemistry POCT: Revenue Forecast by Region, 2023–2028
  • Immunochemistry POCT Industry: Revenue Forecast by Therapy Areas, 2023–2028
  • Molecular POCT: Growth Metrics, Global, 2023
  • Molecular POCT: Revenue Forecast, Global, 2023–2028
  • Molecular POCT: Revenue Forecast by Region, 2023–2028
  • Molecular POCT Industry: Revenue Forecast by Therapy Areas, Global, 2023–2028

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

19 Nov 2026   |   Global   |   Technology Research

Programmable Vaccines: AI-Designed Antigens and Next-Generation Rapid Platforms

Traditional vaccine development is an empirical, time-consuming process that often leads to a high failure rate. With the proven clinical success of RNA vaccines, there has been a focus on accelerating the development of vaccines to address the growing incidence of infectious diseases and emerging p...

17 Nov 2026   |   Global   |   Frost Radar

Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026

Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...

16 Nov 2026   |   North America   |   Frost Radar

Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026

This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...

03 Nov 2026   |   North America   |   Market Research

Enterprise Imaging Market, United States, 2025–2030

Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...

02 Nov 2026   |   Global   |   Market Research

Continuous Glucose Monitoring Market, Global, 2026

The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.